This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignee: Alexion Pharmaceuticals, Inc.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Innovations by Anthony Rossomando
Introduction
Anthony Rossomando is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of rare diseases. His work focuses on innovative methods that aim to improve patient outcomes.
Latest Patents
Anthony holds a patent for "Methods of treating Mucopolysaccharidosis IIIB (MPSIIIB)." This patent outlines methods for treating the central nervous system (CNS) in human patients with mucopolysaccharidosis (MPS) who have an intact blood-brain barrier. The treatment involves the intravenous administration of recombinant NaGlu. This innovative approach has the potential to enhance the quality of life for patients suffering from this condition.
Career Highlights
Anthony is currently employed at Alexion Pharmaceuticals, Inc., a leading biopharmaceutical company known for its focus on rare diseases. His role at the company allows him to work on groundbreaking therapies that address unmet medical needs. With a patent portfolio that includes 1 patent, he continues to push the boundaries of medical science.
Collaborations
Throughout his career, Anthony has collaborated with talented professionals in the field. Notable coworkers include Anthony Quinn and Sandra Rojas-Caro, who contribute to the innovative environment at Alexion Pharmaceuticals.
Conclusion
Anthony Rossomando's work exemplifies the spirit of innovation in the medical field. His contributions to the treatment of Mucopolysaccharidosis IIIB highlight the importance of research and development in improving patient care. His ongoing efforts at Alexion Pharmaceuticals promise to lead to further advancements in the treatment of rare diseases.